Phase 2 Study of an HIV-1 Canarypox Vaccine (vCP1452) Alone and in Combination With rgp120Nina D. Russell, Lawrence Corey, Kent J. Weinhold et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2006Cited by 104
Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adultsGeoffrey J. Gorse, Nina D. Russell, Lindsey R. Baden et al.|Vaccine|2007Cited by 59
Timing of Plasmid Cytokine (IL-2/Ig) Administration Affects HIV-1 Vaccine Immunogenicity in HIV-Seronegative SubjectsLindsey R. Baden, William A. Blattner, Cecilia Morgan et al.|The Journal of Infectious Diseases|2011Cited by 25